Lexicon Pharmaceuticals Inc. diskutieren
Lexicon Pharmaceuticals Inc.
WKN: A14SSK / Symbol: LXRX / Name: Lexicon PHARM / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
2,11 €
1,74 %
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its price target lowered by analysts at Piper Sandler from $10.00 to $6.00. They now have an "overweight" rating on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals (NASDAQ:LXRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals (LXRX) had its price target raised by HC Wainwright from $4.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals (LXRX) had its price target raised by Citigroup Inc. from $2.10 to $2.30. They now have a "buy" rating on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals (LXRX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals (LXRX) had its price target raised by Citigroup Inc. from $2.30 to $3.10. They now have a "buy" rating on the stock.
Ratings data for LXRX provided by MarketBeat
Lexicon Pharmaceuticals (LXRX) was upgraded by Zacks Research from "hold" to "strong-buy".
Ratings data for LXRX provided by MarketBeat
Neueste Beiträge
Barclays_PLC in Hochschild Mining plc diskutieren